Table 1.
N. | % | |
---|---|---|
Sex | ||
Male | 17 | 71 |
Female | 7 | 29 |
Performance status | ||
ECOG 0 | 5 | 21 |
ECOG 1 | 12 | 50 |
ECOG ≥ 2 | 7 | 29 |
Primary site | ||
Pancreas | 15 | 63 |
Lung | 4 | 17 |
Small intestine | 2 | 8 |
Unknown | 2 | 8 |
Rectum | 1 | 4 |
Functional syndrome | ||
Carcinoid syndrome | 4 | 17 |
Insulinoma | 2 | 8 |
VIPoma | 1 | 4 |
Grade | ||
Grade 1 | 6 | 25 |
Grade 2 | 9 | 37.50 |
Grade 3 | 9 | 37.50 |
Metastatic site | ||
Liver | 23 | 96 |
Lymph nodes | 18 | 75 |
Peritoneum | 6 | 25 |
Bone | 4 | 17 |
Others | 5 | 21 |